The Japanese experience with sirolimus-eluting stent implantation in the infarct-related artery: Five years of observation from the J-PMS study

Journal of Cardiology

Volumn 61, Issue 5, 2013, Pages 321-325

  Adachi, Taichi ^a   Kotani, Jun ichi ^a   Ikari, Yuji ^b   Kyo, Eisho ^c   Nakamura, Masato ^d   Yokoi, Hiroyoshi ^e  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c Kusatsu Heart Center   (Japan)

^d TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^e KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Follow up study; Stents

Indexed keywords

RAPAMYCIN;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CALCIFICATION; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING SINUS STENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; IMPLANTATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; REVASCULARIZATION; SMOKING; STENT THROMBOSIS; TREATMENT DURATION;

AGED; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; SIROLIMUS; TREATMENT OUTCOME;

EID: 84877604033     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.12.013     Document Type: Article

References (21)

1. Kastrati A., Dibra A., Spaulding C., Laarman G.J., Menichelli M., Valgimigli M., Di Lorenzo E., Kaiser C., Tierala I., Mehilli J., Seyfarth M., Varenne O., Dirksen M.T., Percoco G., Varricchio A., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007, 28:2706-2713.
2. Brar S.S., Leon M.B., Stone G.W., Mehran R., Moses J.W., Brar S.K., Dangas G. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 2009, 53:1677-1689.
3. Mauri L., Silbaugh T.S., Garg P., Wolf R.E., Zelevinsky K., Lovett A., Varma M.R., Zhou Z., Normand S.L. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008, 359:1330-1342.
4. Steg P.G., Fox K.A., Eagle K.A., Furman M., Van de Werf F., Montalescot G., Goodman S.G., Avezum A., Huang W., Gore J.M. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009, 30:321-329.
5. Nakazawa G., Finn A.V., Joner M., Ladich E., Kutys R., Mont E.K., Gold H.K., Burke A.P., Kolodgie F.D., Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118:1138-1145.
6. Finn A.V., Nakazawa G., Kolodgie F., Virmani R. Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?. Eur Heart J 2009, 30:1828-1830.
7. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011, 58:84-91.
8. Tanaka A., Sakakibara M., Okumura S., Okada K., Ishii H., Murohara T. Comparison of early outcomes after primary stenting in Japanese patients with acute myocardial infarction between clopidogrel and ticlopidine in concomitant use with proton-pump inhibitor. J Cardiol 2012, 60:7-11.
9. Ikari Y., Kotani J., Kozuma K., Kyo E., Nakamura M., Yokoi H., Group J.P.S. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration: one year results from CYPHER Stent Japan Post-Marketing Surveillance Registry (J-PMS). Circ J 2009, 73:1038-1044.
10. Kotani J., Ikari Y., Kyo E., Nakamura M., Yokoi H., Furuno K., Inui H., Kozuma K. Five-year outcomes of Cypher™ coronary stent: report from J-PMS Study. Cardiovasc Interv Ther 2012, 27:63-71.
11. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
12. Mehran R., Rao S.V., Bhatt D.L., Gibson C.M., Caixeta A., Eikelboom J., Kaul S., Wiviott S.D., Menon V., Nikolsky E., Serebruany V., Valgimigli M., Vranckx P., Taggart D., Sabik J.F., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011, 123:2736-2747.
13. Spaulding C., Teiger E., Commeau P., Varenne O., Bramucci E., Slama M., Beatt K., Tirouvanziam A., Polonski L., Stella P.R., Clugston R., Fajadet J., de Boisgelin X., Bode C., Carrie D., et al. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty). JACC Cardiovasc Interv 2011, 4:14-23.
14. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009, 119:987-995.
15. Urban P., Gershlick A.H., Guagliumi G., Guyon P., Lotan C., Schofer J., Seth A., Sousa J.E., Wijns W., Berge C., Deme M., Stoll H.P. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. Circulation 2006, 113:1434-1441.
16. Kang S.J., Mintz G.S., Akasaka T., Park D.W., Lee J.Y., Kim W.J., Lee S.W., Kim Y.H., Whan Lee C., Park S.W., Park S.J. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011, 123:2954-2963.
17. Sianos G., Papafaklis M.I., Daemen J., Vaina S., van Mieghem C.A., van Domburg R.T., Michalis L.K., Serruys P.W. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 2007, 50:573-583.
18. Goldstein J.A., Demetriou D., Grines C.L., Pica M., Shoukfeh M., O'Neill W.W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000, 343:915-922.
19. Asakura M., Ueda Y., Yamaguchi O., Adachi T., Hirayama A., Hori M., Kodama K. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001, 37:1284-1288.
20. Okazaki S., Yokoyama T., Miyauchi K., Shimada K., Kurata T., Sato H., Daida H. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study. Circulation 2004, 110:1061-1068.
21. Nissen S.E., Tuzcu E.M., Schoenhagen P., Crowe T., Sasiela W.J., Tsai J., Orazem J., Magorien R.D., O'Shaughnessy C., Ganz P. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005, 352:29-38.